SMS Clinical Research, LLC

Mesquite, Texas 75149

3 studies enrolling now · 24 studies all time

What they study most

COVID-19, Coronavirus Disease 2019, Covid-19, Covid19, Diabetes Mellitus, Type 1, Healthy Adults, Hypogonadism, Influenza A, Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention, Moderately to Severely Active Crohns Disease, Non-Cystic Fibrosis Bronchiectasis, Pneumococcal Disease

Studies at this site

• A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study to Learn About How a New Pneumococcal Vaccine Works in Infants. — Recruiting now
• A Study to Learn About mRNA Vaccines Against Influenza in Adults — Recruiting now
• Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis — Running, not enrolling
• Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes — Running, not enrolling
• A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years — Completed
• Efficacy and Safety of NVX-CoV2705 — Running, not enrolling
• Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals — Completed
• CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG) — Running, not enrolling
• A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia — Completed
• A Phase 4 Study to Evaluate Adrenal Function in Hypogonadal Men Treated With JATENZO® for 12 Months — Running, not enrolling
• EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19 — Completed
• A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications. — Completed
• A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications — Stopped early
• Study of Obeldesivir in Nonhospitalized Participants With COVID-19 — Completed
• A Study to Investigate Safety, Tolerability, and PK of Oral Doses of TCK-276 in Patients With Rheumatoid Arthritis — Completed
• Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection — Stopped early
• A Study of Rilematovir (JNJ-53718678) in Adult Outpatients With Respiratory Syncytial Virus (RSV) Infection — Stopped early
• A Study to Evaluate EDP-235 in Non-hospitalized Adults With COVID-19 — Completed
• Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection — Completed
• A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19 — Completed
• A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection — Completed
• Assessment of INS1007 in Participants With Non-Cystic Fibrosis Bronchiectasis — Completed
• Sargramostim Use in COVID-19 to Recover Patient Health — Completed